CAVAMAX® W7 PHARMA
CAVAMAX® W7 PHARMA is pharmaceutical grade beta-cyclodextrin from Wacker Chemie AG. CAVAMAX® W7 PHARMA with seven glucose units has the mid-size cavity of the parent cyclodextrins. It is useful for stabilizing, solubilizing or delivering intermediate size molecules, e.g. menthol.
DMF Type IV. No.14620
All the information provided is in accordance with the present state of our knowledge. Nonetheless, we disclaim any warranty or liability whatsoever and reserve the right, at any time, to effect technical alterations. The information provided, as well as the product's fitness for an intended application, should be checked by the buyer in preliminary trials. Contractual terms and conditions always take precedence. This disclaimer of warranty and liability also applies particularly in foreign countries with respect to third parties' rights.
- Solubilization, stabilization, delivery and isolation of mid-sized active ingredients, e.g. menthol, thymol, macrolides
- Enhancement of both oral bioavailability and taste masking of pharmaceutical and agrochemical active ingredients; enabling delayed release of volatile materials
Storage at room temperature in sealed containers under dry conditions is recommended. CAVAMAX® W7 PHARMA has a shelf life of at least 36 months when stored inunbroken original packaging in dry storage areas. The best use before date of each batch is shown on the product label. Storage beyond the date specified on the label does not necessarily mean that the product is no longer usable. In this case however, the properties required for the intended use must be checked for quality assurance reasons.
Please choose an application for viewing your product matches.